UNSPSC 51362504: Etodroxizine

This classification denotes a sedative and hypnotic with the molecular formula C23H31ClN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CI1S3XAK7O, chemically known as 3,6-dioxaoctanol, 8-(4-(4-chlorophenylphenylmethyl)piperazinyl)- but generally known as etodroxizine, which bears US NIH Compound Identifier 63345. European Medicines Agency schedules Etodroxizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07317MIG.

UNSPSC 51362504 Etodroxizine, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity in the dataset—Seminole County, Florida's IFB 60459723LAS—is tagged to this code but solicits naloxone and safe drug deactivation systems, not etodroxizine, representing a mismatch between the code assignment and the work actually being bought. Etodroxizine is a pharmaceutical compound with narrow clinical application; state and local governments do not appear to be actively procuring it as a standalone product line under this Commodity code at this time.

Seminole County's opportunity, posted June 30, 2026, with a response deadline of July 26, 2023, calls for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB requires vendors to submit bids electronically, include all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify and drug-free workplace certification. The contract carries a two-year initial term with an optional one-year renewal and includes a three-month probationary termination clause. No set-aside designations are specified. Given the code's apparent inactivity and the disconnect between the code label and the actual procurement, this Commodity code warrants low priority in portfolio evaluation.